DUBLIN--(BUSINESS WIRE)--The "Transcatheter Aortic Valve Implantation (TAVI) Market by Procedure (Transfemoral Implantation, Transapical Implantation, and Transaortic Implantation) - Global ...

Aortic valve disease is a major clinical concern, and its treatment has traditionally relied on surgical aortic valve replacement (AVR) via open‐heart surgery. In recent decades, transcatheter aortic ...

Introduction European valvular heart disease guidelines define women as a ‘special group’. To explore what factors have led ...

Caranx Medical announced the first clinical use of its TaviPilot Soft platform for robotic transcatheter aortic valve ...

DUBLIN--(BUSINESS WIRE)--The "Global Transcatheter Aortic Valve Implantation (TAVI) Market: Industry Analysis & Outlook (2018-2022)" report has been added to ResearchAndMarkets.com's offering. "Global ...

Caranx Medical ("Caranx"), a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving ...

- The non-surgical Navitor TAVI system offers best-in-class deliverability and access through small vessels, expanding treatment options for patients with severe aortic stenosis ABBOTT PARK, Ill., May ...

Transcatheter aortic valve implantation has evolved as a viable therapeutic option for high-risk, elderly patients with symptomatic aortic stenosis in select cardiac centers with experience of the ...

A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons, has identified early hemodynamic valve deterioration (HVD) in more than 6% of patients just ...

Transcatheter Aortic Valve Implantation (TAVI) gives broadly comparable results to conventional open surgery, with equal efficacy, faster recovery time and improved quality of life at one year, ...

“This 3rd-generation TRINITY technology could be a game-changer for TAVI.” Prof. Dr. Christian Hengstenberg, MD, German Heart Center, Munich REGENSBURG, Germany–(BUSINESS WIRE)–March 7, 2014– ...

Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...